Search research articles
Contact Us
Filters
Showing results (181-190 of 227) with videos related to
Page
of 23
Sort By:
Cancer Research Communications
|
July 24, 2025
Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7-Expressing CRPC Models
Benjamin C Brim, Andres F Leon, Erica L Beatson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 3, 2016
Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein
Wei Wang, Linh T T Nguyen, Christopher Burlak, et al.
Nature
|
May 5, 2016
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos, Ruin Moaddel, Patrick J Morris, et al.
Cancer Research Communications
|
March 7, 2024
Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
Yasuhiro Arakawa, Ukhyun Jo, Suresh Kumar, et al.
Cancer Cell
|
May 3, 2024
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas
Jaewoo Choi, Michele Ceribelli, James D Phelan, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2007
Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation
Yuli Xie, ShiXian Deng, Craig J Thomas, et al.
Biorxiv : the Preprint Server for Biology
|
October 3, 2023
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib
Ying Pang, Qi Li, Zach Sergi, et al.
Cell Reports. Medicine
|
October 20, 2023
High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma
Nadia Arang, Simone Lubrano, Michele Ceribelli, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 24, 2019
Antidepressant-relevant concentrations of the ketamine metabolite (2<i>R</i>,6<i>R</i>)-hydroxynorketamine do not block NMDA receptor function
Eric W Lumsden, Timothy A Troppoli, Scott J Myers, et al.
Iscience
|
April 17, 2025
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib
Ying Pang, Qi Li, Zach Sergi, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 227) with videos related to
Sort By:
Page
of 23
Cancer Research Communications
|
July 24, 2025
Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7-Expressing CRPC Models
Benjamin C Brim, Andres F Leon, Erica L Beatson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 3, 2016
Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein
Wei Wang, Linh T T Nguyen, Christopher Burlak, et al.
Nature
|
May 5, 2016
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos, Ruin Moaddel, Patrick J Morris, et al.
Cancer Research Communications
|
March 7, 2024
Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
Yasuhiro Arakawa, Ukhyun Jo, Suresh Kumar, et al.
Cancer Cell
|
May 3, 2024
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas
Jaewoo Choi, Michele Ceribelli, James D Phelan, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2007
Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation
Yuli Xie, ShiXian Deng, Craig J Thomas, et al.
Biorxiv : the Preprint Server for Biology
|
October 3, 2023
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib
Ying Pang, Qi Li, Zach Sergi, et al.
Cell Reports. Medicine
|
October 20, 2023
High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma
Nadia Arang, Simone Lubrano, Michele Ceribelli, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 24, 2019
Antidepressant-relevant concentrations of the ketamine metabolite (2<i>R</i>,6<i>R</i>)-hydroxynorketamine do not block NMDA receptor function
Eric W Lumsden, Timothy A Troppoli, Scott J Myers, et al.
Iscience
|
April 17, 2025
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib
Ying Pang, Qi Li, Zach Sergi, et al.
Page
of 23